$DXCMDEXCOM INC
Rep. Jefferson Shreve disclosed that the filer sold · $15,001 – $50,000 · Pharma & Biotech
View transaction source status →Traded May 12, 2025Notified May 15, 2025Filed Jun 22, 202541 days to file
Owner: FilerOriginal filing ↗
Pharma & Biotech
$DXCM
DEXCOM INC
Transactions involving this ticker in readable 2025 House reports. This page describes disclosure activity, not the issuer’s performance and not a recommendation to trade.
3
Purchases
4
Sales
3
Filers
6
Reports
Transaction history
Who disclosed trading $DXCM?
$DXCMDEXCOM INC
Rep. Jefferson Shreve disclosed that the filer purchased · $15,001 – $50,000 · Pharma & Biotech
View transaction source status →Traded May 8, 2025Notified May 15, 2025Filed Jun 22, 202545 days to file
Owner: FilerOriginal filing ↗
$DXCMDEXCOM INC
Rep. Rob Bresnahan disclosed that the filer purchased · $1,001 – $15,000 · Pharma & Biotech
View transaction source status →Traded May 15, 2025Notified May 15, 2025Filed Jun 9, 202525 days to file
Owner: FilerOriginal filing ↗
$DXCMDEXCOM INC
Rep. Jefferson Shreve disclosed that the filer sold · $15,001 – $50,000 · Pharma & Biotech
View transaction source status →Traded Apr 7, 2025Notified Apr 25, 2025Filed May 8, 202531 days to file
Owner: FilerOriginal filing ↗
$DXCMDEXCOM INC
Rep. Rob Bresnahan disclosed that the filer sold · $1,001 – $15,000 · Pharma & Biotech
View transaction source status →Traded Apr 8, 2025Notified Apr 8, 2025Filed Apr 28, 202520 days to file
Owner: FilerOriginal filing ↗
$DXCMDEXCOM INC
Rep. Rob Bresnahan disclosed that the filer purchased · $1,001 – $15,000 · Pharma & Biotech
View transaction source status →Traded Feb 25, 2025Notified Feb 25, 2025Filed Mar 27, 202530 days to file
Owner: FilerOriginal filing ↗
$DXCMDEXCOM INC
Rep. Kevin Hern's filing reports that a joint account sold · $50,001 – $100,000 · Pharma & Biotech
View transaction source status →Traded Dec 31, 2024Notified Jan 2, 2025Filed Jan 15, 202515 days to file
Owner: JointOriginal filing ↗